在内牙治疗中对不同灌方案的比较研究
Midhun Paul1, Rekha V Ravi2, Chintu Sundaresan3
1Department of Conservative Dentistry and Endodontics, St Gregorios Dental College, Kothamangalam, Kerala, India.
Journal of pharmacy & bioallied sciences
|February 10, 2025
概括
与和EDTA相比,化 (5.25%) 是内牙治疗中最有效的灌剂,可显著减少细菌,清除碎片和涂抹层.
科学领域:
- 牙周内治疗 牙周内治疗
- 微生物学 微生物学
- 牙科材料科学 牙科材料科学
背景情况:
- 根管灌对于去除细菌,有机组织和碎片至关重要.
- 有效的灌方案可以提高内牙治疗的结果.
研究的目的:
- 为了比较三种不同的灌方案在内牙治疗中的疗效.
- 为了评估细菌,碎片和涂抹层的去除,使用二酸盐,赫西丁和EDTA.
主要方法:
- 一个体外研究涉及60个提取的单根人类牙.
- 牙被分为三组,每组用不同的灌剂处理:5.25%的二,2%的赫西丁或17%的EDTA.
- 使用微生物学技术和扫描电子显微镜 (SEM) 来评估灌效率.
主要成果:
- 二 (5.25%) 显示了细菌负载 (4.77 ± 0.54) 中最高的平均日志减少.
- SEM分析显示,高化的净度为85%,而赫西丁的净度为70%,EDTA的净度为50%.
- 在减少细菌和去除碎片/污垢层方面,二显著超过了赫西丁和EDTA (P < 0.05).
结论:
- 5.25%的二酸盐是内牙科手术中最有效的灌剂.
- 这种灌剂在减少细菌数量和冲洗根管碎片和涂抹层方面表现出色.
相关概念视频
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...


